Proud to Support Research Excellence

2022-06-17

Innovaderm has generously donated $350,000 to The Montreal Dermatology Research Institute (MDRI) to fund educational initiatives and research into skin-related neglected tropical diseases. We are proud to support the work of a world-class organization dedicated to the development of new treatments and therapeutic interventions that may have a significant impact on the quality of life of thousands of individuals.

The MDRI was created in 2017 to promote education and conduct studies on the prevention, screening, diagnosis and treatment of dermatological diseases. Our donation is a testament to our shared goal of creating a brighter future for people with skin disease.

Partner with us to invest in the future of skin care.

Newsletter

Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Innovaderm Will Be At SID Annual Meeting In Dallas!

Innovaderm’s team is gearing up to meet with you at the SID (Society for Investigative Dermatology) annual meeting in Dallas on May 15-18, 2024! Dr. Jankicevic, Sherry, France and Vincent cannot wait to share latest dermatology research breakthroughs and collaborate with industry leaders. If you're also attending, be sure to connect with our team to […]

Innovaderm Will be at the AMWC in Monaco!

We’re thrilled to announce that our esteemed colleague, Laura Tomat, will be representing us at the prestigious Aesthetic & Anti-aging Medicine World Congress (AMWC) on March 27-29! Laura is eager to connect and share insights with fellow experts in the field. If you’re attending the conference and would like to discuss the latest trends in […]

Innovaderm’s Leading Role and Experience in Propelling Dermatology Science Forward Showcased at the AAD

Innovaderm’s expertise was once again highlighted during a late-breaking session at the American Academy of Dermatology (AAD) annual meeting, in San Diego. On March 9, 2024, Dr. Laura K. Ferris presented the results of a recent phase 2b study of an investigational therapy for Moderate-to-Severe Plaque Psoriasis. Dr. Robert Bissonnette, Innovaderm’s founder and CEO, is […]

Proud to Support Research Excellence

Newsletter subscription resources

Other recent articles

Innovaderm Will Be At SID Annual Meeting In Dallas!

Innovaderm Will be at the AMWC in Monaco!

Innovaderm’s Leading Role and Experience in Propelling Dermatology Science Forward Showcased at the AAD